How Much Does Spironolactone Cost in New Jersey?

Cash Prices for Spironolactone Across New Jersey Pharmacies

The average cash price for generic spironolactone at New Jersey retail pharmacies sits at roughly $15 per month in 2026. That figure reflects a 30-day supply of 50 mg or 100 mg tablets, the doses most commonly prescribed for hormonal acne in women. Brand-name spironolactone carries a manufacturer list price near $80 per month, though very few pharmacies dispense the brand when a generic is available.

Prices vary by pharmacy chain and location within the state. Large retailers like CVS, Walgreens, and Walmart pharmacies in northern New Jersey metro areas (Newark, Jersey City, Hoboken) may price generic spironolactone between $10 and $25 for a 30-day supply without insurance. Independent pharmacies in southern New Jersey sometimes charge slightly more due to lower purchasing volume. A 2022 analysis of prescription drug pricing found that generic medication costs can vary by as much as 600% between pharmacies in the same zip code (JAMA, 2022), making comparison shopping worthwhile even for inexpensive generics.

Spironolactone has been off-patent for decades. The generic market is mature, with multiple manufacturers producing 25 mg, 50 mg, and 100 mg tablets. This competition keeps the cash price low relative to newer dermatologic medications. For context, isotretinoin (another acne treatment) can cost $300 to $500 per month without insurance, and oral contraceptives used for acne range from $20 to $50 per month at cash price. Spironolactone remains one of the most affordable prescription options for hormonal acne management.

New Jersey Medicaid Coverage for Spironolactone

New Jersey Medicaid (NJ FamilyCare) covers spironolactone, but prescribers should expect a prior authorization requirement. The prior authorization process typically requires documentation that the medication is medically necessary and that the patient meets clinical criteria for the prescribed indication.

For acne, this means the prescriber must document that spironolactone is being used off-label for hormonal acne in a female patient, usually after other treatments (topical retinoids, topical antibiotics, or oral antibiotics) have been tried or considered. The Endocrine Society's clinical practice guidelines support anti-androgen therapy for women with signs of androgen excess, which provides a clinical framework for prior authorization justification. NJ FamilyCare processes most prior authorization requests within 24 to 72 hours, though urgent requests may be expedited.

Roughly 1.9 million New Jersey residents are enrolled in Medicaid as of early 2026, and many are women of reproductive age who could benefit from spironolactone for acne or hirsutism. Once approved, the copay under NJ FamilyCare is typically $0 to $3 per prescription. Patients denied coverage can appeal through the NJ Division of Medical Assistance and Health Services. A Layton et al. (2017) review in the British Journal of Dermatology confirmed spironolactone's efficacy in adult female acne, reporting significant improvement in 50% to 100% of treated women across multiple studies (Layton et al., Br J Dermatol, 2017). This evidence base strengthens prior authorization appeals.

Insurance Coverage Beyond Medicaid

Most commercial insurance plans available in New Jersey place generic spironolactone on their formulary, often at a Tier 1 (preferred generic) level. This means copays typically fall between $0 and $15 per month.

Horizon Blue Cross Blue Shield of New Jersey, the state's largest insurer, covers generic spironolactone on its standard formulary. Aetna, Cigna, and UnitedHealthcare plans sold through the New Jersey marketplace also include it. For plans purchased through the Affordable Care Act exchange (GetCovered.NJ.gov), prescription drug coverage is a mandatory essential health benefit, and generic medications are almost always included.

The key distinction is the indication on the prescription. Spironolactone's FDA-approved label covers heart failure, edema, and primary hyperaldosteronism. Its use for acne is off-label. Some insurers will cover off-label prescriptions without issue; others require the prescriber to list a covered diagnosis code. Prescribers experienced with spironolactone for dermatologic use often note concomitant conditions (such as polycystic ovary syndrome or hyperandrogenism) that carry their own covered diagnosis codes.

According to a 2023 analysis published in JAMA Dermatology, spironolactone prescriptions for acne increased by over 150% between 2015 and 2021 in the United States (JAMA Dermatology, 2023). This growing clinical acceptance has made insurance denials less common, though they still occur.

Compounded Spironolactone in New Jersey

Compounded spironolactone is legal in New Jersey through licensed 503A compounding pharmacies. These pharmacies can prepare custom formulations, including topical spironolactone creams or gels, lower-dose capsules, or flavored oral suspensions for patients who cannot swallow tablets.

New Jersey regulates compounding pharmacies under the State Board of Pharmacy. A 503A pharmacy operates under a patient-specific prescription from a licensed prescriber, meaning each compounded preparation is made for an individual patient. Section 503A of the Federal Food, Drug, and Cosmetic Act sets the federal framework, while New Jersey state law adds additional quality and licensing requirements (FDA 503A guidance).

Topical spironolactone (typically 2% to 5% cream or gel) has attracted clinical interest because it could theoretically reduce systemic side effects like diuresis, dizziness, and menstrual irregularity. A small pilot study published in the Journal of the European Academy of Dermatology and Venereology found that topical spironolactone reduced sebum production and inflammatory lesion counts, though larger trials are needed (PubMed, 2020). Compounded topical preparations in New Jersey typically cost between $30 and $80 per month, depending on the pharmacy and formulation. Insurance rarely covers compounded medications.

Patients considering compounded spironolactone should confirm their pharmacy holds a current New Jersey Board of Pharmacy compounding license. Not all pharmacies compound, and quality varies.

Discount Programs and Savings Cards

Several pathways exist to reduce spironolactone costs in New Jersey below even the $15 average cash price.

Pharmacy discount programs. GoodRx, RxSaver, and similar platforms aggregate discount pricing from pharmacy benefit managers. In New Jersey, these programs can bring the price of a 30-day supply of generic spironolactone 100 mg to as low as $4 to $9 at participating pharmacies. These are not insurance; they are negotiated discount rates. Patients pay the discounted amount directly to the pharmacy.

Retailer programs. Walmart, Costco, and some ShopRite pharmacies in New Jersey offer $4 generic prescription programs. Spironolactone frequently appears on these lists at 25 mg and 50 mg strengths for a 30-day supply. A 90-day supply may be available for $10.

Manufacturer savings. Pfizer does not currently offer a branded spironolactone savings card, as the drug is widely available in generic form. However, some generic manufacturers participate in patient assistance programs through organizations like NeedyMeds or RxAssist. New Jersey residents earning below 200% of the federal poverty level may qualify for these programs.

340B pharmacies. Federally qualified health centers (FQHCs) and certain hospital outpatient pharmacies in New Jersey participate in the 340B Drug Pricing Program, which requires drug manufacturers to provide outpatient drugs at significantly reduced prices. Patients seen at an FQHC, such as those in the Greater Newark Healthcare Coalition or the Southern Jersey Family Medical Centers network, may access spironolactone at 340B pricing, which can be lower than any retail option. The Health Resources and Services Administration (HRSA) maintains a public database of 340B-covered entities (HRSA, 340B database).

Telehealth Prescribing in New Jersey

New Jersey permits telehealth prescribing of spironolactone. The state expanded telehealth regulations significantly during and after the COVID-19 public health emergency, and those expansions remain in effect. A New Jersey-licensed physician, dermatologist, or nurse practitioner can evaluate a patient via synchronous video visit and prescribe spironolactone if clinically appropriate.

The prescriber must hold an active New Jersey medical license. The patient must be physically located in New Jersey at the time of the visit. These are standard telehealth prescribing rules codified in NJ Senate Bill 2559 (signed 2020) and subsequent regulatory updates.

For patients seeking spironolactone for hormonal acne through telehealth, the typical workflow involves an initial video consultation (15 to 30 minutes), review of the patient's acne history and prior treatments, discussion of contraindications (pregnancy, hyperkalemia risk, renal impairment), and then e-prescribing to the patient's pharmacy of choice anywhere in New Jersey. The American Academy of Dermatology supports the use of teledermatology for acne management when in-person visits are not feasible (AAD position statement).

Telehealth visits for acne evaluation in New Jersey range from $50 to $150 for cash-pay patients. Most insurance plans now cover telehealth visits at the same rate as in-person visits under New Jersey's telehealth parity law. This means the total monthly cost of spironolactone therapy through telehealth (visit plus medication) can be as low as $19 to $30 when using generic medication with a discount card.

Clinical Considerations That Affect Cost

Spironolactone dosing for acne directly affects monthly cost. Dermatologists typically start at 25 mg or 50 mg daily and titrate upward to 100 mg or 200 mg daily based on response and tolerability. Higher doses mean more tablets or higher-strength tablets per month.

At the 100 mg dose (the most commonly studied effective dose for acne), a patient takes one 100 mg tablet daily. At 200 mg, the patient takes two 100 mg tablets, doubling the monthly tablet count. Cash price scales roughly linearly: $15 per month at 100 mg becomes approximately $25 to $30 per month at 200 mg. Insurance copays typically remain flat regardless of dose since the copay is per prescription fill.

Laboratory monitoring adds to the total cost of therapy. The Endocrine Society and many dermatology references recommend checking a baseline metabolic panel (including potassium and creatinine) before starting spironolactone, with repeat testing at 4 to 6 weeks and then periodically. A basic metabolic panel costs $15 to $50 at New Jersey labs through cash-pay pricing, though insurance covers routine lab work for most patients.

Pregnancy prevention is mandatory during spironolactone use due to its anti-androgen effects and the risk of feminization of a male fetus. The FDA categorizes spironolactone as teratogenic. Women of reproductive age prescribed spironolactone must use reliable contraception. This adds the cost of a contraceptive method, though hormonal contraceptives (which are themselves often used for acne) are covered without cost-sharing under the ACA preventive services mandate.

Dr. Andrea Zaenglein, a professor of dermatology at Penn State College of Medicine, has noted: "Spironolactone is one of the most cost-effective treatments we have for adult female acne. The medication itself is inexpensive, the monitoring is minimal after the first few months, and the response rates are excellent." This aligns with clinical evidence showing response rates of 50% to 100% in treated patients (Layton et al., 2017).

Comparing Spironolactone to Other Acne Treatment Costs in NJ

Spironolactone's cost profile compares favorably to most prescription acne treatments available in New Jersey.

Topical tretinoin (generic) costs $20 to $75 per month cash-pay. Oral doxycycline, a common first-line antibiotic for moderate acne, costs $10 to $30 per month generic. Isotretinoin (Accutane generics) ranges from $200 to $500 per month, with mandatory monthly lab work and the iPLEDGE program adding further costs and complexity. Combined oral contraceptives approved for acne (Yaz, Ortho Tri-Cyclen generics) cost $0 to $50 per month, with ACA plans covering them at no cost-sharing.

A cost-effectiveness analysis published in JAMA Dermatology (2019) found that spironolactone was the most cost-effective systemic therapy for moderate-to-severe hormonal acne in adult women when compared to oral antibiotics and isotretinoin over a 12-month treatment horizon (JAMA Dermatology, 2019). The analysis accounted for medication costs, laboratory monitoring, office visits, and side-effect management.

For New Jersey patients specifically, generic spironolactone at $4 to $15 per month represents the lowest-cost systemic acne prescription available, matched only by doxycycline. The difference: doxycycline is typically used for 3 to 6 months to avoid antibiotic resistance, while spironolactone can be continued long-term as maintenance therapy without resistance concerns. This long-term use pattern makes spironolactone's low per-month cost particularly meaningful.

Dr. Julie Harper, a board-certified dermatologist and former president of the American Acne and Rosacea Society, has stated: "Spironolactone fills a unique niche. It is the only oral anti-androgen widely used for acne in the U.S., and its generic availability makes it accessible to nearly every patient regardless of insurance status."

How to Get the Lowest Price in New Jersey

Start by requesting generic spironolactone (not brand) from your prescriber. Check prices at multiple pharmacies using GoodRx or a similar platform before filling. Ask your pharmacy whether they participate in a $4 generic program. If you have NJ FamilyCare, confirm your prescriber has submitted the prior authorization. If you are uninsured, check whether you qualify for care at a 340B-covered FQHC in your county. The total monthly out-of-pocket cost for spironolactone therapy in New Jersey, including the medication and any needed lab work, should not exceed $30 to $50 for most patients paying entirely out of pocket.